First AD

Second AD

Breast Cancer

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Post-Conference Perspectives: Understanding HER2-Low Breast Cancer

OncLive News Network®

DAI-21-OSV1372 - /news-network/post-conference-perspectives-understanding-her2-low-breast-cancer

Experts take a look at clinical data behind novel antibody drug conjugates and consider how they may impact the management of HER2-low breast cancer.

Treating HER2-low Breast Cancer With Novel Antibody Drug Conjugates 

Current Landscape of HER2 Testing in Breast Cancer

Strategies in Identifying and Stratifying HER2 Status in Breast Cancer

HER2-low Breast Cancer: Practical Applications of ADC Therapy 